This site is intended for healthcare professionals
Drug news

Adynovate (recombinant factor VIII) approved by FDA for hemophilia A, in pediatric patients under 12 years of age and in surgical settings- Shire

Read time: 1 mins
Last updated:28th Jun 2017
Published:28th Dec 2016
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest